Therefore, we evaluated the relationship between the stromal LOX‐1/CD8 status and Wnt/β‐catenin activation in CRC specimens to understand why the CRC patients with stromal LOX‐1‐L/CD8+ CTL‐L had poorer prognosis compared to other CRC patients. The gene discussed is OLR1; the disease is colorectal carcinoma.